Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Pluri Inc (PLUR.US)$ Pluri Says US NIAID Will Provide Company With $1.4M From July 1, 2024 To June 30, 2025; NIAID Exercised Its Option For Year Two Of The Three-year $4.2M Contract It Entered Into With Pluri In July 2023
Benzinga· just
The company will manufacture the PLX-R18 cell therapy and to conduct both in vitro and in vivo studies to develop PLX-R18 as a potential novel treatment for hematopoietic complications of the acute radiation syndrome (H-ARS).
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2563 Views
Comment
Sign in to post a comment
    3607Followers
    23Following
    53KVisitors
    Follow